Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

In clinical trials, most people taking 1.7-mg and 2.4-mg doses of Wegovy had lost 5% to 15% of their body weight after 68 weeks of ... healthcare professional before taking any medication.

Wegovy (semaglutide) has become a social media sensation as a weight-loss treatment after being name-checked by numerous celebrities, driving huge demand around the world and stretching Novo ...

Novo Nordisk's sales of blockbuster obesity drug Wegovy grew by a massive 79% in the third quarter, in a relief to investors after disappointing ... up existing stock before placing new orders ...

after spotting the ad at Madison Avenue and East 49th Street. Michael Wood wondered if Bagizza was working with Wegovy, to which owner Michael Park has said he definitely is not. J.C. Rice ...

Fuelled by dividends from the company behind blockbuster weight-loss drug Wegovy and diabetes treatment ... with the opening of an office in Mumbai after significant investments already made ...

Small compounders have until April 22 to stop making and selling versions of Novo Nordisk’s Wegovy; large compounders have until May 22. It is not clear how the F.D.A. will enforce these deadlines.

Semaglutide, the main ingredient in Ozempic and Wegovy, has been linked to an increased likelihood of hair loss. Researchers assessed data from 16 million patients from 2006 to 2020 and compared ...